TREM2 Human

Triggering Receptor Expressed on Myeloid Cells 2 Human Recombinant
Cat. No.
BT18422
Source
Escherichia Coli.
Synonyms
Triggering receptor expressed on myeloid cells 2, Triggering receptor expressed on monocytes 2, TREM-2, TREM2, Trem2a, Trem2b, Trem2c.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

TREM2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 181 amino acids (19-161 a.a) and having a molecular mass of 20.4kDa.
TREM2 is fused to a 38 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
TREM2, also known as triggering receptor expressed on myeloid cells 2, is a cell surface receptor found on microglia and other myeloid cells. It plays a critical role in immune regulation, particularly within the central nervous system. TREM2 functions by associating with the adaptor protein TYROBP to initiate downstream signaling pathways. These pathways regulate various cellular processes, including microglial survival, proliferation, phagocytosis, and inflammatory responses. Mutations in the TREM2 gene have been linked to an increased risk of developing neurodegenerative diseases such as Alzheimer's disease.
Description
This product consists of the extracellular domain of human TREM2, specifically amino acids 19-161, expressed in E. coli and purified to a high degree. The recombinant protein is not glycosylated and has a molecular weight of 20.4 kDa. To facilitate purification and detection, a 38 amino acid Histidine tag is fused to the N-terminus.
Physical Appearance
Clear and colorless solution that has been sterilized by filtration.
Formulation
This solution contains 0.25mg/ml of TREM2 protein in a buffer composed of 20mM Tris-HCl (pH 8.0), 0.15M NaCl, 10% glycerol, and 1mM DTT.
Stability
To ensure optimal product stability, it is recommended to store the solution at 4°C for short-term use (2-4 weeks). For longer-term storage, freezing at -20°C is recommended. The addition of a carrier protein such as HSA or BSA (0.1%) is advised for extended storage. Repeated freezing and thawing should be avoided.
Purity
The purity of this protein is greater than 90%, as assessed by SDS-PAGE analysis.
Synonyms
Triggering receptor expressed on myeloid cells 2, Triggering receptor expressed on monocytes 2, TREM-2, TREM2, Trem2a, Trem2b, Trem2c.
Source
Escherichia Coli.
Amino Acid Sequence
MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSHMHN TTVFQGVAGQ SLQVSCPYDS MKHWGRRKAW CRQLGEKGPC QRVVSTHNLW LLSFLRRWNG STAITDDTLG GTLTITLRNL QPHDAGLYQC QSLHGSEADT LRKVLVEVLA DPLDHRDAGD LWFPGESESF EDAHVEHSIS R.

Product Science Overview

Genetic and Molecular Basis

The TREM2 gene provides instructions for making the TREM2 protein, which is found on the surface of myeloid cells . This protein interacts with the TYROBP gene product to mediate signal transduction, leading to various immune responses . Mutations in the TREM2 gene have been linked to several neurodegenerative diseases, including Alzheimer’s disease .

Role in Neurodegenerative Diseases

TREM2 is particularly significant in the context of neurodegenerative diseases. Homozygous mutations in TREM2 can cause early-onset progressive presenile dementia, while heterozygous point mutations increase the risk of Alzheimer’s disease . The receptor is involved in the clearance of amyloid-beta plaques, a hallmark of Alzheimer’s disease, by recruiting microglia to the plaques and enhancing their phagocytic activity .

Therapeutic Potential

Recent studies have explored the therapeutic potential of TREM2 activation. For instance, chronic activation of TREM2 in mouse models of amyloid deposition has shown promising results in reducing amyloid-beta levels and improving cognitive functions . These findings suggest that TREM2 activators could be effective in treating Alzheimer’s disease and possibly other neurodegenerative disorders .

Role in Sepsis

In addition to its role in neurodegenerative diseases, TREM2 also plays a critical role in the host defense response to sepsis. It enhances bacterial clearance and improves survival rates in septic conditions . This receptor’s ability to regulate inflammatory responses and facilitate pathogen clearance makes it a potential target for therapeutic interventions in sepsis .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.